Zborník príspevkov z vedeckej konferencie - Department of ...
Zborník príspevkov z vedeckej konferencie - Department of ... Zborník príspevkov z vedeckej konferencie - Department of ...
Figure 7 present MS and MS/MS spectrum of potential metabolite M4. The dominant peak m/z 397.1500 can be seen in the MS spectrum, which corresponds to the mass of hydroxyibuprofen glucuronide [M-H] - ion (theoretical value m/z 397.1504). The difference between the measured and theoretical m/z values is 0.4 mDa (1.0 ppm) what is very good value for calibrated TOF analyzer. The ion m/z 397.1500 was selected as a precursor for obtaining MS/MS spectrum where m/z 193.0365 ion is dominating. The presence of this ion in the MS/MS spectrum suggests that the ion m/z 397.1500 must have glucuronic acid implemented in its structure and the fragmentation of M4 metabolite is occuring with higher probability at the carboxyl group. The peaks corresponding to the ions m/z 221.1175 (hydroxyibuprofen) and m/z 175.0253 (glucuronide) can also be seen in MS/MS spectrum. Based on these facts, we can say that the metabolite M4 is hydroxyibuprofen glucuronide. 8.0 7.0 6.0 5.0 4.0 3.0 2.0 Inten.(x1,000,000) 343.0862(1) [M-H] - 397.1500(1) 1.0 0.0 112.9881 201.1143 243.1225 304.1204 387.1676 495.1250 50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 m/z 1.2 1.1 1.0 0.9 0.8 0.7 0.6 0.5 0.4 0.3 Inten.(x1,000,000) glucuronide 193.0365 M1 C H 3 OH CH 3 MS hydroxyibuprofen glucuronide MS/MS 0.2 0.1 0.0 157.0142 221.1175 193.035 50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 m/z Fig 7: MS (upper) and MS/MS (lower) spectrum of metabolite M4 in negative ionization mode. Ion m/z 397.1500 was taken for MS/MS analysis. Zborník príspevkov z 18. medzinárodnej vedeckej konferencie "Analytické metódy a zdravie loveka", ISBN 978-80-969435-7-9 - 141 - M1 CH 3 O O HO O OH O OH OH glucuronide hotel Falkensteiner, Bratislava 11. - 14. 10. 2010
Figure 8 is showing the MS and MS/MS spectra of the potential metabolite M5. The dominant peak m / z 411.1297 can be seen in the MS spectrum, which corresponds to the mass of carboxyibuprofen glucuronide [M-H] - ion (theoretical value m/z 411.1297). The difference between the measured and theoretical m/z values is 0.0 mDa (0 ppm) what represents an excellent value for TOF analyzer. The ion m/z 411.1297 was selected as a precursor for MS/MS spectrum, where m/z 175.0261 ion is dominating. The presence of this ion in the MS/MS spectrum suggests that the ion m/z 411.1297 must have glucuronic acid implemented in its structure (theoretical value m/z 175.0248). The peak corresponding to m/z 191.1076 ion can also be seen in the MS/MS spectrum what is suggesting the cleavage of CO2 molecule from the carboxyibuprofen ion (m/z 235.0976) and what represents the loss of 43.9900 Da. Based on these facts, we can say that the metabolite M5 is carboxyibuprofen glucuronide. 1.25 1.00 0.75 0.50 Inten.(x10,000,000) 411.1297(1) 0.25 187.0080 372.1112(1) 0.00 113.0278 328.1183 433.1097(1) 511.1493 50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 m/z 2.00 Inten.(x1,000,000) 1.75 1.50 1.25 1.00 0.75 0.50 0.25 175.0261 [M-H] - MS carboxyibuprofen glucuronide glucuronide MS/MS M2-CO2 157.0142 0.00 50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 m/z M2 glucuronide Fig 8: MS (upper) and MS/MS (lower) spectrum of metabolite M5 in negative ionization mode. Ion m/z 411.1297 was taken for MS/MS analysis. Zborník príspevkov z 18. medzinárodnej vedeckej konferencie "Analytické metódy a zdravie loveka", ISBN 978-80-969435-7-9 - 142 - hotel Falkensteiner, Bratislava 11. - 14. 10. 2010
- Page 98 and 99: Conclusion remarks The identificati
- Page 100 and 101: screening, possible interactions am
- Page 102 and 103: The design consists of a factorial
- Page 104 and 105: elative area 15 10 5 -1,68 -1,00 0,
- Page 106 and 107: It can be seen that the programms d
- Page 108 and 109: nevodíkovými atómami izotropne s
- Page 110 and 111: O22—C6—C7 109.57 (15) C10—C11
- Page 112 and 113: [8] S. Teklu, L.L. Gundersen, T. La
- Page 114 and 115: iónom kovu môže by ovplyvnená a
- Page 116 and 117: V alšej asti práce sme študovali
- Page 118 and 119: vzorky, pomer hmotností vzorky a s
- Page 120 and 121: literatúre nenašli informácie. M
- Page 122 and 123: Záver Pri úprave vzorky pôdy met
- Page 124 and 125: galactose-4-epimerase [6, 7]. First
- Page 126 and 127: Abundance Abundance Abundance 1x10
- Page 128 and 129: Galactitol [mmol/mol creatinine] 60
- Page 130 and 131: References [1] J.T.R. Clarke, Clini
- Page 132 and 133: structural information of the analy
- Page 134 and 135: (x10,000,000) 1.5 1:TIC (1.00) 1.4
- Page 136 and 137: 1 st fraction 1.5 1.0 0.5 (x10,000,
- Page 138 and 139: 1 st fraction 1.5 1.0 0.5 (x10,000,
- Page 140 and 141: RAPID LIQUID CHROMATOGRAPHY-MASS SP
- Page 142 and 143: the LC-ESI-IT-TOF MS analyzer. HPLC
- Page 144 and 145: (x10,000,000) 1:TIC (1.00) 4:TIC (1
- Page 146 and 147: Figure 5 is showing MS and MS/MS sp
- Page 150 and 151: MS and MS/MS spectra of potential m
- Page 152 and 153: DVOUROZMĚRNÁ KAPALINOVÁ CHROMATO
- Page 154 and 155: řřů ěř Pnčč ěě : ččěP2D
- Page 156 and 157: řěůčťě čě č ěě Obr. 6.
- Page 158 and 159: Obr. 9. Separaci metabolitů indolo
- Page 160 and 161: STANOVENIE OXIDANÝCH PRODUKTOV OXI
- Page 162 and 163: e d c b a G NO - 3 NO - 2 NO - 2 NO
- Page 164 and 165: Na obr. 4b je elektroforeogram z IT
- Page 166 and 167: Vhodnos navrhnutého analytického
- Page 168 and 169: Experimentálna as CZE separácie b
- Page 170 and 171: Séria kalibraných meraní modelov
- Page 172 and 173: Výsledky a diskusia Na obr. 2 sú
- Page 174 and 175: Tab. 2: Parametre regresných rovn
- Page 176 and 177: Tab. 3: Opakovatenosti migraných a
- Page 178 and 179: chloridu, typickej makrozložky v C
- Page 180 and 181: kationického roztoku elektrolytu b
- Page 182 and 183: Tab. 2: Stanovenie aniónov a kati
- Page 184 and 185: CHARAKTERIZÁCIA RP-HPLC FRAKCIONOV
- Page 186 and 187: Obr. 2. RP-HPLC profil vzorky HK Al
- Page 188 and 189: Obr. 6. RP-HPLC profily frakcií vz
- Page 190 and 191: Zoznam použitej literatúry [1] Ha
- Page 192 and 193: a druhá kolóna kontaktným vodivo
- Page 194 and 195: c b a 1000 1500 tm [s] 2000 Obr. 3:
- Page 196 and 197: Záver ITP-CZE uskutonená použit
Figure 7 present MS and MS/MS spectrum <strong>of</strong> potential metabolite M4. The dominant peak m/z 397.1500 can be seen in<br />
the MS spectrum, which corresponds to the mass <strong>of</strong> hydroxyibupr<strong>of</strong>en glucuronide [M-H] - ion (theoretical value<br />
m/z 397.1504). The difference between the measured and theoretical m/z values is 0.4 mDa (1.0 ppm) what is very good<br />
value for calibrated TOF analyzer. The ion m/z 397.1500 was selected as a precursor for obtaining MS/MS spectrum where<br />
m/z 193.0365 ion is dominating. The presence <strong>of</strong> this ion in the MS/MS spectrum suggests that the ion m/z 397.1500 must<br />
have glucuronic acid implemented in its structure and the fragmentation <strong>of</strong> M4 metabolite is occuring with higher probability<br />
at the carboxyl group. The peaks corresponding to the ions m/z 221.1175 (hydroxyibupr<strong>of</strong>en) and m/z 175.0253<br />
(glucuronide) can also be seen in MS/MS spectrum. Based on these facts, we can say that the metabolite M4 is<br />
hydroxyibupr<strong>of</strong>en glucuronide.<br />
8.0<br />
7.0<br />
6.0<br />
5.0<br />
4.0<br />
3.0<br />
2.0<br />
Inten.(x1,000,000)<br />
343.0862(1)<br />
[M-H] -<br />
397.1500(1)<br />
1.0<br />
0.0<br />
112.9881<br />
201.1143<br />
243.1225<br />
304.1204<br />
387.1676<br />
495.1250<br />
50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 m/z<br />
1.2<br />
1.1<br />
1.0<br />
0.9<br />
0.8<br />
0.7<br />
0.6<br />
0.5<br />
0.4<br />
0.3<br />
Inten.(x1,000,000)<br />
glucuronide<br />
193.0365<br />
M1<br />
C<br />
H 3<br />
OH<br />
CH 3<br />
MS<br />
hydroxyibupr<strong>of</strong>en glucuronide<br />
MS/MS<br />
0.2<br />
0.1<br />
0.0<br />
157.0142 221.1175<br />
193.035<br />
50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 m/z<br />
Fig 7: MS (upper) and MS/MS (lower) spectrum <strong>of</strong> metabolite M4 in negative ionization mode. Ion m/z 397.1500 was taken<br />
for MS/MS analysis.<br />
<strong>Zborník</strong> <strong>príspevkov</strong><br />
z 18. medzinárodnej <strong>vedeckej</strong> <strong>konferencie</strong><br />
"Analytické metódy a zdravie loveka", ISBN 978-80-969435-7-9<br />
- 141 -<br />
M1<br />
CH 3<br />
O<br />
O<br />
HO<br />
O<br />
OH<br />
O<br />
OH<br />
OH<br />
glucuronide<br />
hotel Falkensteiner, Bratislava<br />
11. - 14. 10. 2010